Serran- Aguilera, Lucia et al. published their research in European Journal of Medicinal Chemistry in 2020 |CAS: 2567-29-5

The Article related to benzylquinolinium benzylpyridinium benzylquinuclidinium preparation choline kinase inhibition, structure benzylpyridinium benzylquinolinium benzylquinuclidinium inhibition choline kinase antitumor activity, benzylpyridinium bromide complex choline kinase mol crystal structure and other aspects.Computed Properties of 2567-29-5

On December 1, 2020, Serran- Aguilera, Lucia; Mariotto, Elena; Rubbini, Gianluca; Castro Navas, Francisco Fermin; Marco, Carmen; Carrasco-Jimenez, Maria Paz; Ballarotto, Marco; Macchiarulo, Antonio; Hurtado-Guerrero, Ramon; Viola, Giampietro; Lopez-Cara, Luisa Carlota published an article.Computed Properties of 2567-29-5 The title of the article was Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism. And the article contained the following:

Seeking for new anticancer drugs with strong antiproliferative activity and simple mol. structure, we designed a novel series of compounds based on our previous reported pharmacophore model composed of five moieties. Antiproliferative assays on four tumoral cell lines and evaluation of human choline kinase CKα1 enzymic activity was performed for these compounds Among tested mols., those ones with biphenylmethyl groups showed better enzymic and antiproliferative activities. Docking and crystallization studies validate the hypothesis and confirm the results. The most active compound, the biphenylmethylquinolinium bromide I·Br-, induced significant arrest of the cell cycle in G0/G1 phase that ultimately lead to apoptosis, following the mitochondrial pathway, as demonstrated for other choline kinase inhibitors. However, addnl. assays reveal that the inhibition of choline uptake could also be involved in the antiproliferative activity of this class of compounds The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).Computed Properties of 2567-29-5

The Article related to benzylquinolinium benzylpyridinium benzylquinuclidinium preparation choline kinase inhibition, structure benzylpyridinium benzylquinolinium benzylquinuclidinium inhibition choline kinase antitumor activity, benzylpyridinium bromide complex choline kinase mol crystal structure and other aspects.Computed Properties of 2567-29-5

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary